Health Tech is a topic tracked in our intelligence system with 5 linked articles.
Oura filed a new patent suit in Texas federal court seeking damages and a permanent injunction to block US sales of Ultrahuman's Ring Pro — citing two patents including one granted just two days before filing — weeks after shelving its own $2.2B IPO and months after Ultrahuman's $70M Qualcomm-backed raise at a ~$365M valuation.
AI drug-development firm Pathos raised a $237 million Series E led by Bristol Myers Squibb at a ~$3 billion valuation, expanding from oncology into neurology with Tempus AI datasets and a BMS partnership initially targeting Alzheimer's treatments.
A STAT+ Health Tech newsletter teaser noting the FDA has finalized its guidance on prescription drug use-related software (welcomed by pharma) and that telehealth players are pushing GLP-1s for addiction.
AI calorie-tracking app Cal AI turned an influencer-heavy go-to-market strategy into $30M+ revenue in two years and was acquired by MyFitnessPal in March for an undisclosed sum.
DOJ officials used the STAT Summit to warn healthcare executives that the Trump administration is escalating healthcare fraud enforcement, explicitly invoking Theranos as the cautionary archetype.
Startup Intero Biosystems is selling lab-grown human intestinal organoids to drug developers as an alternative to animal testing, aiming to scale production and broaden its organoid platform — a one-line flag on a space buoyed by regulatory tailwinds, but with no financials or deal detail.
Subscribe for real-time topic updates and unlimited access to our intelligence platform.